-------------------------------------------
OMB APPROVAL
-------------------------------------------
OMB Number:
Expires:
Estimated average burden
hours per form...................
-------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Palomar Medical Technologies, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
697529-10-5
- --------------------------------------------------------------------------------
(CUSIP Number)
Adam D. Eilenberg
Ehrenreich Eilenberg Krause & Zivian LLP
11 East 44th Street, 17th Floor
New York, N.Y. 10017
(212) 986-9700
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 19, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
<PAGE>
CUSIP No. 697529-10-5 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The Rockside Foundation
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER 5,408,600 (including 1,800,000
SHARES warrants exercisable at $3.00 per share (the "Warrants"))
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 10,587,050 (including 3,000,000 Warrants)
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 5,408,600 (including 1,800,000 Warrants)
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.42% (10.78% if not taking into account 3,000,000 Warrants)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 697529-10-5 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mark T. Smith
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 3,713,150 (including 1,200,000 Warrants)
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 10,587,050 (including 3,000,000 Warrants)
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 3,713,150 (including 1,200,000 Warrants)
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.42% (10.78% if not taking into account 3,000,000 Warrants)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 697529-10-5 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Logg Investment Research, Inc.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 6,000
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 10,587,050 (including 3,000,000 Warrants)
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 6,000
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,330,800 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.42% (10.78% if not taking into account 3,000,000 Warrants)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 697529-10-5 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas O'Brien
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 18,100
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 10,587,050 (including 3,000,000 Warrants)
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 18,100
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.42% (10.78% if not taking into account 3,000,000 Warrants)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 697529-10-5 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The R. Templeton Smith Foundation
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 1,441,200
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 10,587,050 (including 3,000,000 Warrants)
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 1,441,200
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
10,587,050 (including 3,000,000 Warrants)
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.42% (10.78% if not taking into account 3,000,000 Warrants)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Schedule 13D
Item 1. Security and Issuer
This statement relates to the Common Stock, $.01 par value, of Palomar
Medical Technologies, Inc. (the "Issuer"), which has its principal executive
office at 45 Hartwell Avenue, Lexington, MA 02173. This statement is filed
pursuant to Rule 13d-2(a) with respect to securities owned by the reporting
persons specified herein as of January 19, 1999 and amends the Schedule 13 D
filed on August 3, 1998 and Amendment No. 1 filed on December 22, 1998
(collectively the "Schedule 13D"). Except as set forth herein, the Schedule 13D
is hereby restated in its entirety.
Item 3. Source and Amount of Funds or Other Consideration
Since December 18, 1998 and through January 19, 1999, the Reporting Persons
have acquired 1,256,250 shares of the Common Stock of the Issuer (the
"Additional Shares") in open market purchases at prices ranging between $.7188
per share and $.84 per share. The Additional Shares acquired and Warrants held
by the Reporting Persons as of January 19, 1999 are listed below:
<PAGE>
<TABLE>
<CAPTION>
Reporting Shares held on Shares Issuable Additional Total Holdings as
Person date of upon exercise Shares of 1/19/99 (including
Amendment No. 1 of Warrants Acquired in Shares issuable
to Schedule 13D exercisable Open Market upon exercise
including Shares within 60 days Purchases of Warrants)
issuable upon
exercise of Warrants
<S> <C> <C> <C> <C>
The Rockside 5,408,600 1,800,000 -- 5,408,600
Foundation
Mark T. Smith 3,041,900 1,200,000 671,250 3,713,150
Logg 6,000 -- -- 6,000
Investment
Research, Inc.
Thomas O' 18,100 -- -- 18,100
Brien
The R. Templeton 856,200 585,000 1,441,200
Smith Foundation
</TABLE>
The source of funds for the 1,256,250 Additional Shares of Common Stock
purchased was personal.
As of November 24, 1998, the 3,000,000 Warrants (the "Warrants") acquired
by The Rockside Foundation ("Rockside") and Mark T. Smith ("Smith") in July 1998
became exercisable within 60 days, and are therefore deemed to be presently
exercisable. The $3.00 exercise price of the Warrants is substantially in excess
of the current market price for the Common Stock and neither Rockside nor Smith
have any current intention of exercising any of their Warrants. If the shares of
Common Stock issuable upon exercise of the Warrants are included with the shares
of Common Stock currently held by the Reporting Persons, as provided in Rule
13(d)-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), the percentage of the entire class of Common Stock beneficially held by
the Reporting Persons is 14.42%. Without including such shares of Common Stock,
the percentage of the entire class of Common Stock beneficially held by the
Reporting Persons is 10.78%.
Item 4. Purpose of Transaction
Each of the Reporting Persons acquired the Additional Shares of Common
Stock for investment purposes. Although they have no current intention to do so,
depending on market conditions and other factors, the Reporting Persons may
acquire additional shares, or, subject to the provisions of Section 16 of the
Exchange Act, sell all or a portion of their shares of Common Stock or Warrants.
The Reporting Persons have no plans or proposals which relate to or would result
in any of the actions set forth in subparagraphs (a) through (j) of Item 4.
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: January 25, 1999
THE ROCKSIDE FOUNDATION
By: /s/ John B. Haley
----------------------------------
Name: John B. Haley
Title: President
/s/ Mark T. Smith
----------------------------------
Mark T. Smith
LOGG INVESTMENT RESEARCH, INC.
By: /s/ Thomas O'Brien
----------------------------------
Name: Thomas O'Brien
Title: President
/s/ Thomas O'Brien
----------------------------------
Thomas O'Brien
THE R. TEMPLETON SMITH FOUNDATION
By: /s/ Edward C. Smith
----------------------------------
Name: Edward C. Smith
Title: Treasurer
(120496DTI)
